Holen Sie sich die Stockscreener-App
3.59
1.41%
0.05
Handel nachbörslich:
3.59
Schlusskurs vom Vortag:
$3.54
Offen:
$3.48
24-Stunden-Volumen:
6,355
Relative Volume:
0.04
Marktkapitalisierung:
$2.03M
Einnahmen:
$927.00K
Nettoeinkommen (Verlust:
$-13.21M
KGV:
-0.017
EPS:
-210.8843
Netto-Cashflow:
$-4.77M
1W Leistung:
-0.21%
1M Leistung:
-35.55%
6M Leistung:
-91.25%
1J Leistung:
+47.46%
1-Tages-Spanne:
$3.48
$3.61
1-Wochen-Bereich:
$3.37
$3.95
52-Wochen-Spanne:
$2.034
$80.10
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
3.59 | 2.00M | 927.00K | -13.21M | -4.77M | -210.88 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
SPRC Should I Buy - Intellectia AI
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
SPRC Stock Price, Quote & Chart | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
Whale Trades: How correlated is SciSparc Ltd to the S P5002026 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn
SciSparc (SPRC) director Dayan Alon reports 3,651-share ownership stake - Stock Titan
SPRC SEC FilingsScisparc 10-K, 10-Q, 8-K Forms - Stock Titan
SPRC Technical Analysis | Trend, Signals & Chart Patterns | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
SciSparc (SPRC) director discloses shares, options and RSU awards - stocktitan.net
SciSparc (SPRC) director reports initial share and option holdings - Stock Titan
SciSparc (SPRC) director Revach Moshe discloses initial share and RSU holdings - Stock Titan
SciSparc (SPRC) CEO Adler Oz details share, option and RSU holdings - Stock Titan
SciSparc (SPRC) director Weiss Amitay details equity holdings - Stock Titan
SciSparc (SPRC) director Vider Lior details shares, options and RSUs - Stock Titan
SciSparc (SPRC) CTO details 5,528 Ordinary Shares and option holdings on Form 3 - Stock Titan
SciSparc (SPRC) director reports 3,651-share stake and RSU grants - Stock Titan
Sentiment Watch: Can SciSparc Ltd stock outperform in a bear marketRecession Risk & Expert Verified Stock Movement Alerts - baoquankhu1.vn
SciSparc stock rallies after AutoMax files motion on pending merger - MSN
Buyout Rumor: Is SciSparc Ltd impacted by rising ratesMarket Performance Report & Low Drawdown Investment Ideas - baoquankhu1.vn
SciSparc subsidiary files patent for depression treatment By Investing.com - Investing.com India
[SCHEDULE 13G] SciSparc Ltd. Passive Investment Disclosure (>5%) - Stock Titan
SciSparc’s NeuroThera-Backed Collaboration Spurs New Depression Therapy Patent Filing - TipRanks
Eli Zamir reports ≤5% stake in SciSparc (NASDAQ: SPRC) - Stock Titan
SciSparc (NASDAQ: SPRC) collaboration advances MEAI-PEA depression patent bid - Stock Titan
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - Bitget
SciSparc subsidiary files patent for depression treatment - Investing.com
SciSparc Ltd. Reports NeuroThera Labs' Patent Application for Innovative Depression Treatment Combining MEAI and PEA - quiverquant.com
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum - TipRanks
SciSparc (Nasdaq: SPRC) unit to acquire 54% of CliniQuantum and lose NeuroThera control - Stock Titan
SciSparc’s Neurothera Labs announces publication of international patent - TipRanks
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - Bitget
SciSparc Ltd. Advances Collaboration with NeuroThera Labs Inc. and Clearmind Medicine Inc. for Novel Combination Therapy Targeting Obesity and MASLD. - Quiver Quantitative
SciSparc: $9.46 Million NeuroThera Deal To Acquire Majority Stake In Quantum Clinical Trials Firm CliniQuantum - Pulse 2.0
SciSparc, Subsidiary NeuroThera Labs Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails - marketscreener.com
NeuroThera to acquire 54% stake in quantum tech firm CliniQ By Investing.com - Investing.com South Africa
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails - Bitget
SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum - TipRanks
SciSparc Ltd. Subsidiary NeuroThera Labs Inc. Enters Share Purchase Agreement to Acquire Majority Stake in CliniQuantum Ltd. - Quiver Quantitative
Neurothera Labs Inc. Announces Definitive Agreement To Acquire Majority Stake In Cliniquantum Ltd. - TheNewswire
Neurothera Labs Inc. Announces Definitive Agreement To Acquire Majority Stake In Cliniquantum Ltd. (2026-03-10) - Seeking Alpha
NeuroThera to acquire 54% stake in quantum tech firm CliniQ - Investing.com
SciSparc Ltd. (SPRC) Schedule 13G/A amendment shows holder ≤5% - Stock Titan
Can SciSparc Ltd. stock resist market sell offsJuly 2025 Update & Accurate Trade Setup Notifications - Naître et grandir
Aug Reactions: What is the implied volatility of SciSparc LtdEarnings Summary Report & Fast Gain Stock Trading Tips - baoquankhu1.vn
Analyst Upgrade: Whats the beta of SciSparc Ltd stockPortfolio Update Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
SciSparc announces publication of Japanese patent application - MSN
SPRC Earnings History & Surprises | EPS & Revenue Results | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
SciSparc announces 1-for-9 reverse share split - Yahoo Finance
SciSparc to implement 1-for-9 reverse stock split Wednesday - Investing.com India
SciSparc to implement 1-for-9 reverse stock split Wednesday By Investing.com - Investing.com Canada
SciSparc Falls 12% After Announcing 1-for-9 Reverse Share Split - Nasdaq
SciSparc to Enact 1-for-9 Reverse Share Split as Outstanding Shares Shrink - TipRanks
Finanzdaten der Scisparc Ltd-Aktie (SPRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):